376 related articles for article (PubMed ID: 11752579)
1. KLF6, a candidate tumor suppressor gene mutated in prostate cancer.
Narla G; Heath KE; Reeves HL; Li D; Giono LE; Kimmelman AC; Glucksman MJ; Narla J; Eng FJ; Chan AM; Ferrari AC; Martignetti JA; Friedman SL
Science; 2001 Dec; 294(5551):2563-6. PubMed ID: 11752579
[TBL] [Abstract][Full Text] [Related]
2. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
3. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
[TBL] [Abstract][Full Text] [Related]
4. Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.
Kimmelman AC; Qiao RF; Narla G; Banno A; Lau N; Bos PD; Nuñez Rodriguez N; Liang BC; Guha A; Martignetti JA; Friedman SL; Chan AM
Oncogene; 2004 Jun; 23(29):5077-83. PubMed ID: 15064720
[TBL] [Abstract][Full Text] [Related]
5. Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.
Lièvre A; Landi B; Côté JF; Veyrie N; Zucman-Rossi J; Berger A; Laurent-Puig P
Oncogene; 2005 Nov; 24(48):7253-6. PubMed ID: 16044160
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations of the KLF6 gene in gastric cancer.
Cho YG; Kim CJ; Park CH; Yang YM; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
Oncogene; 2005 Jun; 24(28):4588-90. PubMed ID: 15824733
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
8. Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer.
Koivisto PA; Hyytinen ER; Matikainen M; Tammela TL; Ikonen T; Schleutker J
J Urol; 2004 Aug; 172(2):506-7. PubMed ID: 15247715
[TBL] [Abstract][Full Text] [Related]
9. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.
Jeng YM; Hsu HC
Int J Cancer; 2003 Jul; 105(5):625-9. PubMed ID: 12740910
[TBL] [Abstract][Full Text] [Related]
10. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
Kremer-Tal S; Reeves HL; Narla G; Thung SN; Schwartz M; Difeo A; Katz A; Bruix J; Bioulac-Sage P; Martignetti JA; Friedman SL
Hepatology; 2004 Nov; 40(5):1047-52. PubMed ID: 15486921
[TBL] [Abstract][Full Text] [Related]
11. Top scorer.
Brooksbank C
Nat Rev Cancer; 2002 Feb; 2(2):81. PubMed ID: 12635169
[No Abstract] [Full Text] [Related]
12. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
13. KLF6: mutational analysis and effect on cancer cell proliferation.
Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
[TBL] [Abstract][Full Text] [Related]
14. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
Narla G; Difeo A; Reeves HL; Schaid DJ; Hirshfeld J; Hod E; Katz A; Isaacs WB; Hebbring S; Komiya A; McDonnell SK; Wiley KE; Jacobsen SJ; Isaacs SD; Walsh PC; Zheng SL; Chang BL; Friedrichsen DM; Stanford JL; Ostrander EA; Chinnaiyan AM; Rubin MA; Xu J; Thibodeau SN; Friedman SL; Martignetti JA
Cancer Res; 2005 Feb; 65(4):1213-22. PubMed ID: 15735005
[TBL] [Abstract][Full Text] [Related]
15. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
Andreoli V; Gehrau RC; Bocco JL
IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
[TBL] [Abstract][Full Text] [Related]
16. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
[TBL] [Abstract][Full Text] [Related]
17. Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
Miyaki M; Yamaguchi T; Iijima T; Funata N; Mori T
Oncology; 2006; 71(1-2):131-5. PubMed ID: 17347589
[TBL] [Abstract][Full Text] [Related]
18. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
19. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
[TBL] [Abstract][Full Text] [Related]
20. A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function.
Slavin DA; Koritschoner NP; Prieto CC; López-Díaz FJ; Chatton B; Bocco JL
Oncogene; 2004 Oct; 23(50):8196-205. PubMed ID: 15378003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
